CD86 and Sepsis: In the present study, the expression of HLA-DR in patients with sepsis was decreased, consistent with the previous studies, but the expression of CD86 in PBMCs was higher in the sepsis group than in the non-sepsis group, especially in non-surviving patients, which is inconsistent with some previous studies [12, 38, 39].